Gene therapy: The breakthrough that inspired Spider-Man | Euronews Tech Talks

3 days ago  ·  4 min read
By Mary Hernandez - usagevpn.com
codex-89c9360bf6a44b859969523a7253078b

Gene Therapy: From Spider-Man Fiction to Real-World Medicine

Usagevpn.com – Gene therapy takes centre stage in Spider-Man: Brand New Day, where Peter Parker faces changing DNA and increasingly dominant spider traits. The superhero storyline is fictional, but its premise draws on real biomedical science: using genetic material to influence the processes behind disease.

In the film, Peter turns to RNA interference to suppress unwanted genetic activity. Outside the cinema, this is a genuine scientific approach. Researchers are using genetic technologies to tackle conditions at their source, initially focusing on diseases caused by a change in one gene and increasingly exploring potential applications in cancer and HIV.

How genetic treatments work

Alberto Auricchio, director of the Telethon Institute of Genetics and Medicine in Naples, professor at the University of Naples and president of the European Society of Gene & Cell Therapy, says the central aim is to address the cause of inherited illness.

“Gene therapy basically targets the root cause of a genetic disease,” Auricchio explained.

These treatments use nucleic acids, including DNA and RNA, to alter a disease-related biological process. Depending on the condition, scientists may add a functioning gene, repair a faulty sequence or reduce the activity of a harmful gene.

There are two main delivery methods. In an in vivo treatment, genetic material is administered directly into the patient’s body. In an ex vivo treatment, cells are removed, modified in a laboratory and then returned to the patient.

Getting the treatment to the correct cells is one of the field’s most important challenges. Modified viruses, known as viral vectors, can carry genetic material into cells, while non-viral delivery systems offer another route. The most suitable option depends on the disease, the affected tissue and the intended treatment effect.

Gene addition, editing and silencing

Gene therapy is not a single technique. Gene addition supplies a working version of a gene that is absent or not functioning correctly. Gene editing can be used to correct a defective sequence, while gene silencing seeks to reduce or switch off harmful genetic activity.

RNA interference falls into the gene-silencing category. That makes it a plausible scientific reference for a Spider-Man story about trying to control an unwanted genetic transformation, even if real treatment development is far more complex than a superhero plot.

The field has advanced from experimental research to patient care. Auricchio noted that approved products are now available, demonstrating that genetic medicines are no longer limited to clinical trials.

“We are beyond clinical trials now. There are approved [gene therapy] products that are available to patients,” Auricchio said.

European milestones and long-term promise

Europe’s first approved in vivo treatment was Glybera, authorised by the European Commission in 2012 for people with lipoprotein lipase deficiency who had severe or repeated pancreatitis attacks. In 2016, Strimvelis became Europe’s first authorised ex vivo treatment. Developed at Hospital San Raffaele in Milan, it is used for severe combined immunodeficiency caused by adenosine deaminase deficiency.

Such milestones illustrate the potential of gene therapy for serious inherited conditions. Unlike medicines that must be taken continuously, some genetic treatments are designed as one-time interventions whose benefits may persist for years.

“There are approved gene therapy drugs, for which we have decades of follow-up in patients where we know that the therapeutic effect is stable over decades, and in theory for the lifetime of the individual,” Auricchio explained.

That potential durability is one reason the technology has generated intense interest. However, it also comes with major practical challenges, especially the high cost of developing and providing advanced therapies.

Frequently Asked Questions

Is gene therapy the same as gene editing?

No. Gene therapy is a broad term for treatments that use DNA or RNA to address disease. Gene editing is one possible approach within the field and may be used to correct a faulty genetic sequence.

Can these treatments be given only once?

Some are designed as one-time treatments, with the aim of producing a long-lasting effect. The expected benefit depends on the specific product, condition and patient.

Is RNA interference used in real medicine?

Yes. RNA interference is a real technique that can reduce or silence selected genetic activity. Its use in a Spider-Man story is fictionalised, but the underlying scientific concept is genuine.

More from this category

Leave a Reply

Your email address will not be published. Required fields are marked *